Forbes Medi-Tech Inc. Provides Update on TSX Listing

VANCOUVER, BRITISH COLUMBIA--(Marketwire - August 12, 2009) - Forbes Medi-Tech Inc. (TSX: FMI)(NASDAQ: FMTI) ("Forbes" or "Company") announced today that it has received notice from the Toronto Stock Exchange ("TSX") that its common shares will be delisted at close of market on September 11, 2009. The delisting decision announced by the TSX relates to Forbes' market capitalization, which has fallen below the designated minimum TSX threshold for continued listing.

The Company's shares continue to be listed on the NASDAQ Capital Market, trading under the symbol FMTI.

About Forbes Medi-Tech

Forbes Medi-Tech Inc. (TSX: FMI)(NASDAQ: FMTI) is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol™ plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower "LDL" cholesterol levels safely and naturally. Building upon established partnerships with leading retailers and manufacturers across the globe, Forbes helps its customers to develop private label and branded products. For more information about Forbes Medi-Tech, please visit www.forbesmedi.com.

Reducol™ is a trademark of Forbes Medi-Tech Inc.

Forward looking Statements and Risks

This News Release contains forward-looking statements and forward-looking information, within the meaning of applicable securities laws (collectively, "forward-looking statements"), regarding the Company's stock exchange listings, specifically, that the Company's shares will be delisted from the TSX at close of market on September 11, 2009 and that the Company's shares continue to be listed on the NASDAQ Capital Market. Forward-looking statements are inherently uncertain, and actual results may differ materially from the forward-looking statements due to a variety of risks, uncertainties and other factors, including, without limitation, the risk that the TSX could determine to accelerate the delisting date of the Company's common shares at any time; the need for the Company to meet NASDAQ's U.S. $1.00 minimum bid price requirement by January 4, 2010, which is not assured, or its shares will be delisted from NASDAQ; the risk that delisting of the Company's shares from TSX could, and from NASDAQ would, have a material adverse effect on the Company's share liquidity and trading price and on the Company's ability to obtain financing or complete a merger, acquisition or other suitable transaction and continue as a going concern. For a further discussion of these and other known risks and uncertainties affecting the Company and its business, please see our latest Annual Information Form / Form 20-F, and other documents filed by us with Canadian and U.S. securities regulatory authorities at www.sedar.com and www.sec.gov. Forward-looking statements are based on the beliefs, assumptions, and expectations of the Company's management at the time they are made, and the Company does not assume any obligation, except as required by law, to update its forward-looking statements if those beliefs, assumptions, or expectations or other circumstances should change.